What's Happening?
The U.S. Senate has passed a bipartisan continuing resolution (CR) to extend government funding through December 11, avoiding a potential shutdown. The resolution was approved with a 90-6 vote and is expected to pass in the House when lawmakers return.
The CR sets the stage for a post-election funding debate, with divisions over defense and non-defense spending. The Senate 340B Bipartisan Working Group, including Sen. Shelley Moore Capito, reintroduced the SUSTAIN 340B Act, which aims to reform the 340B drug pricing program.
Why It's Important?
The passage of the CR is crucial to maintaining government operations and avoiding a shutdown. The upcoming funding debates will address significant budgetary issues, including President Trump's $1.5 trillion defense budget request. The reintroduction of the SUSTAIN 340B Act highlights ongoing efforts to reform healthcare pricing and ensure program integrity. These legislative actions will have broad implications for federal spending priorities and healthcare policy.
What's Next?
The House is expected to consider the CR upon returning from recess, with potential resistance from conservative members. The post-election session will involve intense negotiations over budget allocations, particularly concerning defense spending. The SUSTAIN 340B Act will continue to be a focal point for healthcare policy discussions, with potential impacts on drug pricing and access.
